Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling

This publication has 44 references indexed in Scilit:

• Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
  Molecular Cancer Therapeutics, 2011
• Comparison of Corticotropin-Releasing Factor, Dexamethasone, and Temozolomide: Treatment Efficacy and Toxicity in U87 and C6 Intracranial Gliomas
  Clinical Cancer Research, 2011
• Hallmarks of Cancer: The Next Generation
  Cell, 2011
• Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment
  Journal of Cerebral Blood Flow & Metabolism, 2011
• Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo
  Neuro-Oncology, 2010
• Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma
  Neuro-Oncology, 2010
• Targeting the phosphoinositide 3-kinase pathway in cancer
  Nature Reviews Drug Discovery, 2009
• EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
  Molecular Cancer Therapeutics, 2009
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
  New England Journal of Medicine, 2005
• PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
  Science, 1997